SAN DIEGO, CA—In critically ill adult patients, extended infusion of meropenem correlates with a faster progression to death vs. intermittent infusion of the drug ...

Critically ill sepsis patients did not fare better with prolonged infusions of meropenem compared with intermittent infusions of the beta-lactam antibiotic, a randomized trial showed. Among over 600 ...

The use of intravenous antibiotics to treat patients at home requires that the therapy be provided safely and cost-effectively. Ideal agents for home use provide the necessary spectrum of ...

BETHLEHEM, PA--(Marketwired - Jul 11, 2016) - B. Braun Medical Inc., a leader in infusion therapy and pain management, announced today that it has launched its new 500mg Meropenem for Injection USP ...

Tango I was a randomised, double-blind, double-dummy trial that compared meropenem with vaborbactam (2 g/2 g IV [intravenous] over 3 hours, every 8 hours) with piperacillin with tazobactam (4 g/0.5 g ...

• Meropenem and vaborbactam injection is available as a powder for reconstitution which has to be mixed with 0.9% sodium chloride injection. • Mix the contents of the vial gently and dilute further ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved VABOMERE™ (meropenem and vaborbactam) for injection ...

Please provide your email address to receive an email when new articles are posted on . When comparing continuous vs. intermittent infusions, the absolute difference in 90-day mortality was ...

Bacterial infections remain one of the main causes of morbidity and mortality in patients with hematological malignancies. Different strategies, such as barrier nursing, intravenous immunoglobulins, ...

The rate of meropenem decay did not differ significantly between container types (PVC and elastomeric infusion device) for the 4- and 20-mg/mL solutions. There was a significant difference for the ...

The content of this evidence review was up-to-date in November 2019. See summaries of product characteristics (SPCs), British national formulary (BNF), or the Medicines and Healthcare products ...